Comparison of Serotype Prevalence of Pneumococci Isolated from Middle Ear, Lower Respiratory Tract and Invasive Disease Prior to Vaccination in Iceland
- PMID: 28125588
- PMCID: PMC5270330
- DOI: 10.1371/journal.pone.0169210
Comparison of Serotype Prevalence of Pneumococci Isolated from Middle Ear, Lower Respiratory Tract and Invasive Disease Prior to Vaccination in Iceland
Abstract
Background: Information on pneumococcal serotype distribution before vaccination is a prerequisite for evaluation of vaccine effect. The aim was to investigate the prevalence of pneumococcal serotypes isolated from middle ear (ME), lower respiratory tract (LRT) and from invasive disease (IPD) in Iceland prior to implementation of ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV-10) into the infant vaccination program (April 2011).
Methods and findings: All isolates cultured 2007-2011 from ME, LRT and IPD identified as pneumococci were serotyped and tested for susceptibility at the Clinical Microbiology Department, Landspitali University Hospital that serves approximately 85% of the Icelandic population. Pneumococcal isolates were 1711 and 1616 (94.4%) were available for serotyping and included. Isolates belonging to PHiD-CV10 serotypes (VTs) were 1052 (65.1%). Isolates from ME were 879 (54.4%), with 639 (72.7%) from 0-1 year old patients and 651 of VTs (74%). Isolates from LRT were 564 (34.9%), with 292 (51.8%) from ≥65 years old patients, and 300 (53.2%) of VTs. IPD isolates were 173 (10.7%), although more evenly distributed according to age than isolates from the other sites most were from adults and the youngest age group,101 (58.4%) isolates were of VTs. The most common serotype was 19F, 583 (36.1%). Its prevalence was highest in ME, 400 (45.5%), 172 (30.5%) in LRT and 11 isolates (6.4%), in IPD. Penicillin non-susceptible isolates were 651 (40.3%), mainly belonging to VTs, 611 (93.9%), including 535 (82.2%) of 19F.
Conclusions: Multiresistant isolates of serotype 19F were highly prevalent, especially from ME of young children but also from LRT of adults. Serotype 14 was the most common serotype in IPD. The rate of VTs was high and almost all PNSP were of VTs. There was great difference in vaccine coverage between sampling sites, also reflecting difference in vaccine coverage by age groups.
Conflict of interest statement
Competing Interests: Some of the authors (HE, ÁH and KGK) have received a research grant from GSK, to study the effectiveness of pneumococcal vaccination in Iceland. That study is an investigator initiated study with no conflicting interests related to the current study. GSK did not fund this specific study. There are no patents, products in development or marketed products to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Similar articles
-
Reduction of antimicrobial resistant pneumococci seven years after introduction of pneumococcal vaccine in Iceland.PLoS One. 2020 Mar 17;15(3):e0230332. doi: 10.1371/journal.pone.0230332. eCollection 2020. PLoS One. 2020. PMID: 32182260 Free PMC article.
-
Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.Vaccine. 2012 Dec 31;30 Suppl 6:G37-40. doi: 10.1016/j.vaccine.2012.10.061. Vaccine. 2012. PMID: 23228356
-
Effect of Vaccination on Pneumococci Isolated from the Nasopharynx of Healthy Children and the Middle Ear of Children with Otitis Media in Iceland.J Clin Microbiol. 2018 Nov 27;56(12):e01046-18. doi: 10.1128/JCM.01046-18. Print 2018 Dec. J Clin Microbiol. 2018. PMID: 30257906 Free PMC article.
-
Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.Int J Infect Dis. 2010 Mar;14(3):e197-209. doi: 10.1016/j.ijid.2009.05.010. Epub 2009 Aug 22. Int J Infect Dis. 2010. PMID: 19700359 Review.
-
Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.Clin Microbiol Infect. 2009 Apr;15 Suppl 3:4-6. doi: 10.1111/j.1469-0691.2009.02723.x. Clin Microbiol Infect. 2009. PMID: 19366362 Review.
Cited by
-
Reduction of antimicrobial resistant pneumococci seven years after introduction of pneumococcal vaccine in Iceland.PLoS One. 2020 Mar 17;15(3):e0230332. doi: 10.1371/journal.pone.0230332. eCollection 2020. PLoS One. 2020. PMID: 32182260 Free PMC article.
-
Epidemiology of non-vaccine serotypes of Streptococcus pneumoniae before and after universal administration of pneumococcal conjugate vaccines.Hum Vaccin Immunother. 2021 Dec 2;17(12):5628-5637. doi: 10.1080/21645515.2021.1985353. Epub 2021 Nov 2. Hum Vaccin Immunother. 2021. PMID: 34726580 Free PMC article. Review.
-
Vaccination of Icelandic Children with the 10-Valent Pneumococcal Vaccine Leads to a Significant Herd Effect among Adults in Iceland.J Clin Microbiol. 2019 Mar 28;57(4):e01766-18. doi: 10.1128/JCM.01766-18. Print 2019 Apr. J Clin Microbiol. 2019. PMID: 30651396 Free PMC article.
References
-
- Austrian R. Pneumococcus: the first one hundred years. Rev Infect Dis. 1981;3(2):183–9. - PubMed
-
- Leiberman A, Dagan R, Leibovitz E, Yagupsky P, Fliss DM. The bacteriology of the nasopharynx in childhood. Int J Pediatr Otorhinolaryngol. 1999;49 Suppl 1:S151–3. - PubMed
-
- Cartwright K. Pneumococcal disease in western Europe: burden of disease, antibiotic resistance and management. Eur J Pediatr. 2002;161(4):188–95. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous